SCF API Equivalent: NO-API-Θ1
PCR Mode: Preventative
Biological Target Domain:
Epigenomic drift
Circadian dysregulation
Autonomic nervous system instabilityThe intercept engine prevents initiation of neurodegenerative cascades by stabilizing upstream regulatory systems before mitochondrial and immune interventions occur.
1. SYSTEM PATHOGENESIS TARGET
Epigenomic Drift
Stress / toxin signaling
↓
AhR activation
↓
HDAC overactivity
↓
Plasticity gene suppressionChronobiologic Collapse
SCN desynchronization
↓
Immune clock disruption
↓
Inflammatory biasAutonomic Shock Priming
Sympathetic dominance
↓
Neuroimmune amplification
↓
Perfusion instability2. FDA DRUG MAPPING
A. Epigenomic Plasticity Modulation
Drug | Mechanism | SCF Role |
Valproate | Histone deacetylase inhibition | reopen transcriptional plasticity |
Vorinostat | HDAC inhibition | normalize epigenomic repression |
Justification
HDAC overactivity suppresses genes regulating:
- synaptic plasticity
- neuronal survival
- mitochondrial repair
HDAC inhibition restores gene expression permissivity, enabling later restorative phases.
B. AhR Pathway Dampening
Drug | Mechanism | SCF Role |
Omeprazole | weak AhR signaling modulation | reduce persistent transcriptional activation |
Justification
Chronic AhR activation is associated with:
- neuroinflammation
- oxidative stress
- mitochondrial impairment
Indirect modulation reduces persistent stress-response transcription loops.
C. Circadian Rhythm Stabilization
Drug | Mechanism | SCF Role |
Melatonin | MT1/MT2 receptor agonism | circadian entrainment |
Tasimelteon | selective melatonin receptor agonist | SCN synchronization |
Justification
Circadian alignment restores:
- immune tolerance
- mitochondrial efficiency
- glymphatic clearance
D. Autonomic Stabilization
Drug | Mechanism | SCF Role |
Propranolol | beta-adrenergic blockade | sympathetic suppression |
Ivabradine | sinus node modulation | heart-rate stabilization |
Justification
Autonomic stabilization prevents neuroimmune shock amplification and stabilizes cerebral perfusion.
3. DOSE-TIER ARCHITECTURE (SCF MODEL)
The SCF protocol uses exposure tiers rather than fixed dosing.
Tier | Objective |
Tier 1 | minimal epigenomic reset |
Tier 2 | circadian stabilization |
Tier 3 | autonomic stabilization |
Escalation occurs only when system stability criteria are met.
4. ESCALATION LOGIC
Escalation permitted when:
HRV stable
Sleep architecture normalized
Inflammatory markers stableEscalation blocked when:
autonomic instability
sleep fragmentation
immune activation spike5. BIOMARKER THRESHOLDS
Domain | Biomarker | Escalation Threshold |
Circadian | melatonin amplitude | normalized rhythm |
Autonomic | HRV (RMSSD) | stable or increasing |
Inflammation | IL-6 | non-rising |
Stress axis | cortisol rhythm | diurnal pattern restored |
6. STOP / HOLD RULES
Therapy paused if:
HRV collapse
persistent insomnia
inflammatory spike
cortisol dysregulation7. INTERCEPT ENGINE OUTPUT
Successful intercept phase produces:
epigenomic plasticity restored
circadian alignment achieved
autonomic stability reachedThis creates the biological permissive state required for the Stabilization Engine.